CRBP
CRBP
NASDAQ · Biotechnology

Corbus Pharmaceuticals Holdi

$2.75
-0.27 (-8.80%)
As of Nov 19, 1:25 PM ET ·
Day Range $2.62 — $3.00
52W Range $2.81 — $12.88
Open$2.96
Previous Close$3.01
Day High$3.00
Day Low$2.62
52W High$12.88
52W Low$2.81
Volume—
Avg Volume1.50M
Market Cap71.30M
P/E Ratio—
EPS$-6.17
SectorBiotechnology

Analyst Ratings

Strong Buy
16 analysts
15 Buy 1 Hold 0 Sell
Price Target +342.6% upside
Current
$2.75
Target
$12.15
$8.71 $12.15 avg $17.60

Key Financials

FY 2025 FY 2024 FY 2023
Revenue 72.40M 73.75M 70.02M
Net Income -2,537,554 -2,715,843 -3,439,667
Profit Margin -3.5% -3.7% -4.9%
EBITDA -3,891,696 -4,515,140 -4,413,459
Free Cash Flow -4,239,895 -2,837,667 -3,192,005
Rev Growth +4.2% -7.8% -7.0%
Debt/Equity 0.37 0.31 0.36

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $283.54 -0.86% 50.3 520.47B
AMGN Amgen Inc $438.82 -1.14% 26.9 252.64B
GILD Gilead Sciences Inc $166.53 -1.45% — 208.95B
VRTX Vertex Pharmaceuticals Inc $520.66 -2.94% 33.9 134.82B
REGN Regeneron Pharmaceuticals $923.34 -2.35% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $147.82 -1.06% 7.7 20.98B

CRBP News

No news for CRBP yet

Quick Stats

Market Cap71.30M
P/E Ratio—
EPS$-6.17
Volume—
SectorBiotechnology